Abstracts (PDF file, 1.8MB) - Society for Risk Analysis
Abstracts (PDF file, 1.8MB) - Society for Risk Analysis
Abstracts (PDF file, 1.8MB) - Society for Risk Analysis
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
SRA 2013 Annual Meeting <strong>Abstracts</strong><br />
W2-F.2 Paulson, G; Brennan, T*; US Environmental Protection<br />
Agency; paulson.glenn@epa.gov<br />
Developments in Scientific Peer Review at EPA<br />
The EPA has a strong tradition of scientific peer review. In fact,<br />
the agency’s Peer Review Policy notes that “Peer review of all<br />
scientific and technical in<strong>for</strong>mation that is intended to in<strong>for</strong>m or<br />
support agency decisions is encouraged and expected.” This<br />
presentation will cover the tradition of peer review at the<br />
agency as well as a few of the recent developments on peer<br />
review activities. First, the historical context <strong>for</strong> the importance<br />
and practice of peer review at the agency as summarized in the<br />
EPA Peer Review Handbook will be presented. The Agency is<br />
currently in the process of revising the 2006 third edition of the<br />
Handbook. One area of focus <strong>for</strong> this revision is options to<br />
increase agency oversight of implementation of the peer review<br />
policy. In addition, in May of 2013, EPA’s Acting Administrator<br />
announced a new process <strong>for</strong> peer reviews conducted by panels<br />
of experts selected and managed by EPA contractors. Much of<br />
the new process focuses on opportunities <strong>for</strong> public<br />
engagement on the peer review process and conflict of interest<br />
procedures <strong>for</strong> these contractor-led reviews. Finally, the<br />
Science Advisory Board’s (SAB) process of peer review will be<br />
summarized, from panel selection, to access to meeting<br />
materials, to new ef<strong>for</strong>ts by the SAB Staff Office to enhance<br />
public transparency of the work of the SAB.<br />
P.51 Pawlisz, AV; Conestoga-Rovers& Associates;<br />
apawlisz@craworld.com<br />
Hydraulic Fracturing Failure Rates – Key to<br />
Understanding Actual <strong>Risk</strong>s<br />
Extraction of natural gas deposits via hydraulic fracturing<br />
(fracking) has grown at an unprecedented rate in the United<br />
States and worldwide. For various reasons, this method of<br />
natural resource retrieval has met considerable opposition from<br />
the regulatory community and the public. One of the sensitive<br />
issues is the potential <strong>for</strong> adverse impacts to the environment<br />
and human health, particularly relative to groundwater<br />
extraction, drinking water pollution, deep chemical injection,<br />
well failures, blow outs, on-site spills, air emissions, transport<br />
accidents, and noise. This presentation compiles the most<br />
recent data on various incident/accident/spill/release rates<br />
published by the industry, government agencies, and open<br />
literature. Failure data are used to conduct a predictive risk<br />
assessment where the calculated odds ratios are compared to<br />
those <strong>for</strong> conventional hydrocarbon extraction methods. The<br />
overall objective is to provide an insight on how fracking<br />
compares to other drilling and oil/gas operations in terms of the<br />
potential <strong>for</strong> overall environmental impacts.<br />
M4-A.5 Perez, V*; Garry, MR; Alexander, DD; Tsuji, JS;<br />
Exponent; vperez@exponent.com<br />
Noncancer risk assessment of epidemiological studies of<br />
arsenic and cardiovascular disease<br />
The U.S. Environmental Protection Agency is currently revising<br />
their 1988 noncancer and cancer risk assessments <strong>for</strong> inorganic<br />
arsenic. Cardiovascular disease (CVD) is an endpoint with<br />
considerable recent studies supporting derivation of a<br />
non-cancer reference dose (RfD) <strong>for</strong> arsenic. We conducted a<br />
systematic review of the epidemiologic literature through<br />
March 2013 <strong>for</strong> scientific evidence that may support an RfD<br />
specific to CVD. Eleven cohort and case-control studies<br />
(Taiwan, Bangladesh, and China) assessing the effect of water<br />
arsenic at levels